Annual Current Assets
$120.67 M
+$103.17 M+589.28%
31 March 2024
Summary:
VistaGen Therapeutics annual total current assets is currently $120.67 million, with the most recent change of +$103.17 million (+589.28%) on 31 March 2024. During the last 3 years, it has risen by +$16.55 million (+15.90%). VTGN annual current assets is now at all-time high.VTGN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$99.95 M
-$10.89 M-9.83%
30 September 2024
Summary:
VistaGen Therapeutics quarterly total current assets is currently $99.95 million, with the most recent change of -$10.89 million (-9.83%) on 30 September 2024. Over the past year, it has increased by +$60.87 million (+155.78%). VTGN quarterly current assets is now -21.99% below its all-time high of $128.11 million, reached on 31 December 2023.VTGN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTGN Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +589.3% | +155.8% |
| 3 y3 years | +15.9% | +3.6% |
| 5 y5 years | +785.4% | +2037.1% |
VTGN Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +589.3% | -22.0% | +763.2% |
| 5 y | 5 years | at high | +7536.5% | -22.0% | +7130.6% |
| alltime | all time | at high | >+9999.0% | -22.0% | >+9999.0% |
VistaGen Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $99.95 M(-9.8%) |
| June 2024 | - | $110.84 M(-8.1%) |
| Mar 2024 | $2.98 M(-16.8%) | $120.67 M(-5.8%) |
| Dec 2023 | - | $128.11 M(+227.9%) |
| Sept 2023 | - | $39.08 M(+237.5%) |
| June 2023 | - | $11.58 M(-33.9%) |
| Mar 2023 | $3.58 M(-1.7%) | $17.51 M(-32.8%) |
| Dec 2022 | - | $26.06 M(-29.4%) |
| Sept 2022 | - | $36.91 M(-32.9%) |
| June 2022 | - | $54.99 M(-22.5%) |
| Mar 2022 | $3.65 M(-12.5%) | $71.00 M(-18.2%) |
| Dec 2021 | - | $86.77 M(-10.0%) |
| Sept 2021 | - | $96.44 M(-3.4%) |
| June 2021 | - | $99.83 M(-4.1%) |
| Mar 2021 | $4.16 M(-0.7%) | $104.12 M(-0.8%) |
| Dec 2020 | - | $105.00 M(+557.4%) |
| Sept 2020 | - | $15.97 M(+633.0%) |
| June 2020 | - | $2.18 M(+37.9%) |
| Mar 2020 | $4.19 M(+995.1%) | $1.58 M(+14.3%) |
| Dec 2019 | - | $1.38 M(-70.4%) |
| Sept 2019 | - | $4.68 M(-46.7%) |
| June 2019 | - | $8.78 M(-35.6%) |
| Mar 2019 | $382.80 K(+50.0%) | $13.63 M(+90.9%) |
| Dec 2018 | - | $7.14 M(-15.8%) |
| Sept 2018 | - | $8.48 M(+8.0%) |
| June 2018 | - | $7.85 M(-28.8%) |
| Mar 2018 | $255.20 K(-23.7%) | $11.02 M(-21.1%) |
| Dec 2017 | - | $13.97 M(+500.3%) |
| Sept 2017 | - | $2.33 M(+9.5%) |
| June 2017 | - | $2.13 M(-37.1%) |
| Mar 2017 | $334.30 K | $3.38 M(-41.4%) |
| Dec 2016 | - | $5.77 M(-16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $6.91 M(-20.0%) |
| June 2016 | - | $8.63 M(+909.5%) |
| Mar 2016 | $134.50 K(-18.0%) | $855.30 K(-54.7%) |
| Dec 2015 | - | $1.89 M(+5.0%) |
| Sept 2015 | - | $1.80 M(+12.7%) |
| June 2015 | - | $1.59 M(+1408.3%) |
| Mar 2015 | $164.00 K(-26.5%) | $105.70 K(+40.0%) |
| Dec 2014 | - | $75.50 K(-60.2%) |
| Sept 2014 | - | $189.90 K(-65.8%) |
| June 2014 | - | $554.60 K(+1269.4%) |
| Mar 2014 | $223.20 K(+6.4%) | $40.50 K(-55.6%) |
| Dec 2013 | - | $91.30 K(-40.7%) |
| Sept 2013 | - | $154.00 K(-31.5%) |
| June 2013 | - | $224.70 K(-66.6%) |
| Mar 2013 | $209.70 K(+102.6%) | $671.80 K(+527.9%) |
| Dec 2012 | - | $107.00 K(-67.4%) |
| Sept 2012 | - | $328.40 K(-39.5%) |
| June 2012 | - | $542.90 K(+128.0%) |
| Mar 2012 | $103.50 K(>+9900.0%) | $238.10 K(-15.5%) |
| Dec 2011 | - | $281.90 K(-34.7%) |
| Sept 2011 | - | $432.00 K(-72.6%) |
| June 2011 | - | $1.58 M(>+9900.0%) |
| Mar 2011 | - | $6100.00(+238.9%) |
| Dec 2010 | $400.00(-50.0%) | $1800.00(-21.7%) |
| Sept 2010 | - | $2300.00(+21.1%) |
| June 2010 | - | $1900.00(-45.7%) |
| Mar 2010 | - | $3500.00(+483.3%) |
| Dec 2009 | $800.00(-33.3%) | $600.00(-80.0%) |
| Sept 2009 | - | $3000.00(+100.0%) |
| June 2009 | - | $1500.00(-93.1%) |
| Dec 2008 | $1200.00 | $21.80 K(>+9900.0%) |
| June 2008 | - | $200.00(-33.3%) |
| Mar 2008 | - | $300.00 |
FAQ
- What is VistaGen Therapeutics annual total current assets?
- What is the all time high annual current assets for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual current assets year-on-year change?
- What is VistaGen Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly current assets year-on-year change?
What is VistaGen Therapeutics annual total current assets?
The current annual current assets of VTGN is $120.67 M
What is the all time high annual current assets for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual total current assets is $120.67 M
What is VistaGen Therapeutics annual current assets year-on-year change?
Over the past year, VTGN annual total current assets has changed by +$103.17 M (+589.28%)
What is VistaGen Therapeutics quarterly total current assets?
The current quarterly current assets of VTGN is $99.95 M
What is the all time high quarterly current assets for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly total current assets is $128.11 M
What is VistaGen Therapeutics quarterly current assets year-on-year change?
Over the past year, VTGN quarterly total current assets has changed by +$60.87 M (+155.78%)